{"id":"W3194931195","doi":"10.1177/17474930211042700","title":"Recombinant factor VIIa for hemorrhagic stroke treatment at earliest possible time (FASTEST): Protocol for a phase III, double-blind, randomized, placebo-controlled trial","year":2021,"lang":"en","type":"article","venue":"International Journal of Stroke","topic":"Intracerebral and Subarachnoid Hemorrhage Research","field":"Medicine","cited_by":60,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Ottawa","funders":"National Institute of Neurological Disorders and Stroke","keywords":"Medicine; Factor VIIa; Recombinant factor VIIa; Placebo; Stroke (engine); Double blind; Protocol (science); Randomized controlled trial; Clinical trial; Anesthesia; Surgery; Internal medicine; Coagulation; Alternative medicine; Pathology; Tissue factor","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.001082135,0.0003692458,0.001739223,0.0004134166,0.0001774116,0.0001859144,0.0003245643,0.0001903284,0.001859127],"category_scores_gemma":[0.0007538632,0.0002432396,0.001742091,0.00008790931,0.0001010592,0.0002532005,0.00007517469,0.00033558,0.00003768941],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008627743,"about_ca_system_score_gemma":0.001251444,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001454357,"about_ca_topic_score_gemma":0.0000113046,"domain_scores_codex":[0.9962823,0.0001410851,0.001597291,0.0003599489,0.001110846,0.0005084802],"domain_scores_gemma":[0.9947748,0.001233896,0.000889767,0.0002298297,0.002525721,0.0003460254],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9603319,0.003196657,0.00003533462,0.00008792351,0.00209395,0.0004483714,0.0001534643,0.00001589498,0.01828076,0.0001158832,0.0007477691,0.01449206],"study_design_scores_gemma":[0.9101053,0.006091945,0.000001439846,0.0001630141,0.0004032515,0.0008662568,0.00007324293,0.01172885,0.06735026,0.0001029026,0.002923114,0.0001903862],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"protocol","genre_scores_codex":[0.7504749,0.0001139947,0.003304856,0.005390098,0.001747797,0.23686,0.0003856199,0.00003658162,0.001686152],"genre_scores_gemma":[0.2324738,0.00007387377,0.02075463,0.000390046,0.0080854,0.4333111,0.0003725538,0.000189237,0.3043494],"genre_candidate":"empirical","genre_consensus":null,"teacher_disagreement_score":0.5180011,"threshold_uncertainty_score":0.9990533,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05619082736039098,"score_gpt":0.3972182335860294,"score_spread":0.3410274062256384,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}